[go: up one dir, main page]

MD2975F1 - Remedy in the form of gel for rosacea treatment - Google Patents

Remedy in the form of gel for rosacea treatment Download PDF

Info

Publication number
MD2975F1
MD2975F1 MDA20050259A MD20050259A MD2975F1 MD 2975 F1 MD2975 F1 MD 2975F1 MD A20050259 A MDA20050259 A MD A20050259A MD 20050259 A MD20050259 A MD 20050259A MD 2975 F1 MD2975 F1 MD 2975F1
Authority
MD
Moldova
Prior art keywords
extract
remedy
alcohol
calculated
pharmaceutically acceptable
Prior art date
Application number
MDA20050259A
Other languages
Romanian (ro)
Other versions
MD2975G2 (en
Inventor
Valeriu Rudic
Serghei Melnic
Gheorghe Muset
Nina FIODOROV
Rodica-Ioana Bodrug
Viorica Melnic
Angela Parii
Original Assignee
Valeriu Rudic
Serghei Melnic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeriu Rudic, Serghei Melnic filed Critical Valeriu Rudic
Priority to MDA20050259A priority Critical patent/MD2975G2/en
Publication of MD2975F1 publication Critical patent/MD2975F1/en
Publication of MD2975G2 publication Critical patent/MD2975G2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention refers to medicine, namely to dermatovenerology.The remedy contains extract from Spirulina platensis cyanobacterium strain biomass, extract from marigold flowers (Calendula officinalis), dimethyl sulfoxide, 96% alcohol, gelling agent with pharmaceutically acceptable additives and water in the following ratio, mass. %:extract from Spirulina platensis cyanobacterium strain biomass, calculated for dry substance �0,05...0,50extract from marigold flowers, calculated for dry substance �0,5...3,0dimethyl sulfoxide �����4,0...6,096% alcohol �����3,0...10,0gelling agent with pharmaceutically acceptable additives �10,0...18,0water������the rest.
MDA20050259A 2005-09-09 2005-09-09 Remedy in the form of gel for rosacea treatment MD2975G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050259A MD2975G2 (en) 2005-09-09 2005-09-09 Remedy in the form of gel for rosacea treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050259A MD2975G2 (en) 2005-09-09 2005-09-09 Remedy in the form of gel for rosacea treatment

Publications (2)

Publication Number Publication Date
MD2975F1 true MD2975F1 (en) 2006-02-28
MD2975G2 MD2975G2 (en) 2007-04-30

Family

ID=36002222

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050259A MD2975G2 (en) 2005-09-09 2005-09-09 Remedy in the form of gel for rosacea treatment

Country Status (1)

Country Link
MD (1) MD2975G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009158144A1 (en) * 2008-05-30 2009-12-30 Fairfield Clinical Trials Llc Method and composition for dermatoses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009158144A1 (en) * 2008-05-30 2009-12-30 Fairfield Clinical Trials Llc Method and composition for dermatoses

Also Published As

Publication number Publication date
MD2975G2 (en) 2007-04-30

Similar Documents

Publication Publication Date Title
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
CA2716874A1 (en) A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
NO20075046L (en) Gastroresistant pharmaceutical formulations containing rifaximin
CO6311008A2 (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING AN AGENT THAT ACTIVATES REGULATORY T-CELLS CD4 + CD25 +
MX2010003258A (en) Use of a novel natural agent in cosmetic compositions.
CO6311006A2 (en) PHARMACEUTICAL COMPOSITION INCLUDING AN AGENT THAT ACTIVATES THE REGULATORY T-CELLS CD4 + CD25 + HIGH-DOSE EFFECTIVE
EP3492069A3 (en) Pharmaceutical compositions
ECSP088974A (en) IMIDAZOL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE SYNTHEOSE QUINASA GLYCOGEN (GSK3)
DOP2011000354A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
SI1819227T1 (en) Pharmaceutical formulation of decitabine
CL2004000899A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING TELMISARTAN SODIUM SALT AND A DIURETIC AGENT AND PREPARATION PROCEDURE.
SE0950392L (en) Composition for the treatment of skin conditions
MD3905G2 (en) Remedy of durable action in the form of gel for treatment of parodentium affections (variants)
MD3904F1 (en) Composition for biosoluble medicated film for treatment of parodentium affections and of lesions of tunica mucosa of mouth (variants)
MD2516C2 (en) Anti-inflammatory, antiseptic and antimycotic medicament in the form of gel
MD2975F1 (en) Remedy in the form of gel for rosacea treatment
MD2976F1 (en) Remedy in the form of gel for acnea treatment
MD2211F1 (en) Remedy for treatment of parodontium affections
MD2671F1 (en) Antiviral and antiherpetic medicine in the form of gel
MD3226G2 (en) Process for spermatogenesis optimization to bulls-reproducers
MD3618F1 (en) Gel toothpaste (variants)
MD2936F1 (en) Anti-inflammatory and antimicrobial ointment
MD3340G2 (en) Process for increasing the fecundation capacity of the boar-reproducer semen
MX2008002021A (en) Methods and compositions for soothing oral and nasal tissues.
MD4503B1 (en) Composition for medicated film for the treatment of periodontal diseases and lesions of tunica mucosa of mouth (embodiments)

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees